Avalon to Release Fourth Quarter and Full Year 2005 Financial Results on March 7, 2006
February 28 2006 - 12:28PM
PR Newswire (US)
GERMANTOWN, Md., Feb. 28 /PRNewswire-FirstCall/ -- Avalon
Pharmaceuticals, Inc. (Nasdaq: AVRX; ArcaEx(R)) today announced
that it is scheduled to release financial results for the fourth
quarter and full year of 2005, on Tuesday, March 7, 2006 after the
close of the U.S. financial markets. The Company will host a
conference call on Wednesday, March 8, 2006 at 8:00 a.m. Eastern
Time to provide a company update and discuss the financial results
for the quarter. Interested investors, analysts, members of the
media and the general public can listen to the call live over the
Internet from the investor section of the Company's website or by
dialing the numbers listed below. Conference Call Details:
------------------------ Dial-In: 866-202-3048 (U.S.) 617-213-8843
(International) Passcode: 38984860 Webcast: Please go to
http://www.avalonrx.com/, Investors, within 15 minutes prior to the
call and select the webcast link. The conference call replay will
be available through April 30, 2006 on Avalon's website
(http://www.avalonrx.com/). About Avalon Pharmaceuticals Avalon
Pharmaceuticals is a biopharmaceutical company focused on the
discovery and development of small molecule therapeutics. Avalon
seeks to discover and develop novel therapeutics through the use of
a comprehensive, innovative and proprietary suite of technologies
based upon large-scale gene expression analysis which it calls
AvalonRx(R). Avalon Pharmaceuticals was established in 1999 and is
headquartered in Germantown, Maryland. First Call Analyst: FCMN
Contact: DATASOURCE: Avalon Pharmaceuticals, Inc. CONTACT: Gary
Lessing, Executive Vice President and CFO, Avalon Pharmaceuticals,
+1-301-556-9900, or fax, +1-301-556-9910, or Web site:
http://www.avalonrx.com/
Copyright